4-((4-Methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline
98%
- Product Code: 63871
CAS:
694499-26-8
| Molecular Weight: | 273.3 g./mol | Molecular Formula: | C₁₃H₁₈F₃N₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various biologically active molecules. Its structure, featuring a trifluoromethyl group and a methylpiperazine moiety, makes it valuable in the development of compounds targeting specific receptors or enzymes. It is often employed in the research and production of drugs with potential applications in treating central nervous system disorders, cancer, or infectious diseases. The trifluoromethyl group enhances the compound's metabolic stability and binding affinity, while the methylpiperazine segment contributes to its solubility and interaction with biological targets. Its role is critical in optimizing drug candidates for improved efficacy and pharmacokinetic properties.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Light yellow to yellow Solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿410.00 |
+
-
|
| 1.000 | 10-20 days | ฿1,030.00 |
+
-
|
4-((4-Methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline
This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various biologically active molecules. Its structure, featuring a trifluoromethyl group and a methylpiperazine moiety, makes it valuable in the development of compounds targeting specific receptors or enzymes. It is often employed in the research and production of drugs with potential applications in treating central nervous system disorders, cancer, or infectious diseases. The trifluoromethyl group enhances the compound's metabolic stability and binding affinity, while the methylpiperazine segment contributes to its solubility and interaction with biological targets. Its role is critical in optimizing drug candidates for improved efficacy and pharmacokinetic properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :